Recursion Pharmaceuticals
RXRX
#4000
Rank
A$3.60 B
Marketcap
$9.27
Share price
-3.67%
Change (1 day)
-11.27%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: A$3.60 Billion

As of November 2024 Recursion Pharmaceuticals has a market cap of A$3.60 Billion. This makes Recursion Pharmaceuticals the world's 4000th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2024

End of year Market Cap

Year Marketcap Change
2024A$3.60 B15.39%
2023A$3.12 B45.47%
2022A$2.14 B-46.21%
2021A$3.99 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Recursion Pharmaceuticals was reported to be:

A$2.65 Billion
by Nasdaq info icon info icon
A$2.65 Billion
by CompaniesMarketCap info icon info icon